30 Participants Needed

High-Intensity Interval Training for Cognitive Function in Breast Cancer Patients

(CLARITY Trial)

MN
Christina M Dieli-Conwright, PhD profile photo
Overseen ByChristina M Dieli-Conwright, PhD
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Dana-Farber Cancer Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether a 16-week high-intensity interval training (HIIT) exercise program can improve brain health and heart function in women undergoing chemotherapy for breast cancer. Participants will be randomly assigned to either a HIIT exercise group or a stretching and relaxation group. Women newly diagnosed with stage I-III breast cancer and receiving chemotherapy might be suitable candidates, particularly if they exercise less than one hour per week and do not smoke. As an unphased trial, this study provides a unique opportunity to contribute to research that could enhance quality of life during cancer treatment.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.

What prior data suggests that High-Intensity Interval Training (HIIT) is safe for breast cancer patients undergoing chemotherapy?

Research has shown that high-intensity interval training (HIIT) is generally safe for breast cancer patients. A review of 35 studies with 1,893 participants found that HIIT led to significant physical improvements, suggesting it is relatively safe for those undergoing cancer treatments. Many participants adhere to the HIIT program, with compliance rates between 57% and 83%, indicating it is manageable for most. Additionally, HIIT is linked to a roughly 20% lower risk of cancer recurrence and a reduced risk of death, enhancing its safety profile. While more research is needed, these findings support the potential safety and benefits of HIIT in breast cancer care.12345

Why are researchers excited about this trial?

Researchers are excited about using High-Intensity Interval Training (HIIT) for cognitive function in breast cancer patients because it offers a non-pharmacological approach to improving brain health. Unlike traditional treatments like medication or cognitive therapy, HIIT involves short bursts of intense exercise that can be done at home or in a clinic, making it more accessible and flexible. This method has the potential to enhance cognitive function by promoting better blood flow and brain plasticity, which are crucial for maintaining mental sharpness. Additionally, the exercise-based approach may also improve overall physical health, offering a holistic benefit that goes beyond cognitive improvement.

What evidence suggests that this trial's treatments could be effective for improving cognitive function in breast cancer patients?

Research has shown that High-Intensity Interval Training (HIIT), which participants in this trial may receive, can benefit breast cancer patients undergoing chemotherapy. Studies have found that HIIT improves heart and lung fitness and strengthens muscles. It might also reduce fatigue and emotional issues, common during chemotherapy. Early results suggest that HIIT could enhance brain health in breast cancer patients. Overall, HIIT offers a quick way to improve physical fitness and may enhance quality of life during treatment. Meanwhile, participants in the Attention Control group will engage in a home-based stretching program, serving as an active comparator in this trial.13678

Who Is on the Research Team?

Christina M. Dieli-Conwright, PhD, MPH ...

Christina M Dieli-Conwright, PhD

Principal Investigator

Dana-Farber Cancer Institute

Are You a Good Fit for This Trial?

This trial is for women over 18 with early-stage breast cancer (Stage I-III) who will undergo chemotherapy, do less than an hour of exercise a week, don't smoke, and can travel to DFCI for assessments. They must not be pregnant or have lost significant weight recently, and if they can become pregnant, they need to use birth control and take a pregnancy test.

Inclusion Criteria

Can start a workout program with supervision.
Does not smoke (no smoking during previous 12 months)
Women of child-bearing potential must agree to undergo a pregnancy test and to use adequate contraception prior to study entry and for six months following duration of study participation
See 9 more

Exclusion Criteria

I have a history of heart disease or heart failure.
Patients who are pregnant
You do more than 60 minutes of planned exercise each week.
See 8 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Treatment

Participants receive either High-Intensity Interval Training (HIIT) or Attention Control for 16 weeks

16 weeks
3 weekly supervised exercise sessions (in-person or virtual)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 months
4 month follow-up test, 3 MRIs over 9 months

Open-label extension (optional)

Participants in the Attention Control group may opt into the High-Intensity Interval Training (HIIT) program after the study ends

What Are the Treatments Tested in This Trial?

Interventions

  • Attention Control
  • High-Intensity Interval Training (HIIT)
Trial Overview The study is testing whether a 16-week program of High-Intensity Interval Training (HIIT) can improve brain health and heart function in women receiving chemotherapy for breast cancer. Participants are randomly assigned to either the HIIT program or an attention control group.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: High-Intensity Intervals TrainingExperimental Treatment1 Intervention
Group II: Attention ControlActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Dana-Farber Cancer Institute

Lead Sponsor

Trials
1,128
Recruited
382,000+

American Institute for Cancer Research

Collaborator

Trials
12
Recruited
8,600+

Published Research Related to This Trial

High-intensity interval training (HIIT) is an efficient exercise strategy that can provide similar or even superior health benefits compared to traditional aerobic exercise, making it a time-saving option for improving overall health.
Recent studies suggest that HIIT may be particularly effective in enhancing cognitive function and could serve as a rehabilitation therapy for cognitive impairments related to obesity, diabetes, stroke, and dementia.
[Research advances on high-intensity interval training and cognitive function].Hu, JY., Cai, M., Shang, QH., et al.[2021]
The EPICC Study is a randomized controlled trial involving 254 postmenopausal women with early-stage breast cancer, testing the impact of a six-month moderate-intensity aerobic exercise program on cognitive function during aromatase inhibitor therapy.
This study aims to address cognitive impairment, which affects up to 75% of breast cancer survivors, and if successful, could establish exercise as a low-cost, adaptable intervention to improve cognitive health in this population.
Protocol for Exercise Program in Cancer and Cognition (EPICC): A randomized controlled trial of the effects of aerobic exercise on cognitive function in postmenopausal women with breast cancer receiving aromatase inhibitor therapy.Gentry, AL., Erickson, KI., Sereika, SM., et al.[2023]
High-intensity interval training (HIIT) is a feasible exercise strategy for breast cancer patients undergoing anthracycline-based chemotherapy, with 80% of participants attending the majority of sessions and completing an average of 78 minutes of exercise per week.
The HIIT intervention successfully maintained cardiorespiratory fitness (VO2max) in participants, while the control group experienced a significant decline in VO2max, highlighting the potential of HIIT to counteract the negative effects of chemotherapy on fitness.
Feasibility of high intensity interval training in patients with breast Cancer undergoing anthracycline chemotherapy: a randomized pilot trial.Lee, K., Kang, I., Mack, WJ., et al.[2023]

Citations

Improving Cognitive Function Through High-Intensity ...This 2-arm, single-center, pilot randomized controlled trial will randomize 50 patients with breast cancer undergoing chemotherapy to HIIT or attention control.
High‐intensity interval training in breast cancer patientsHIIT is a time‐efficient alternative to MICT for improving VO 2peak and may also enhance muscle strength and alleviate fatigue and emotional symptoms in breast ...
Improving Cognitive Function Through High-intensity ...This study intends to evaluate whether HIIT can improve cognitive function as well as cardio-respiratory fitness, among patients undergoing chemotherapy for ...
A randomized trial on the feasibility of high-intensity ...The OptiTrain trial showed that HIIT combined with resistance training can significantly improve muscle strength in breast cancer patients ...
Comparison of the effects of high-intensity interval and ...Both HIIT and MICT can improve quality of life in breast cancer patients. •. Further large-scale studies will help determine whether these promising results ...
Clinical updates on the effects of high intensity interval ...Comprehensive meta-analysis of 35 trials (n = 1893 participants) using HIIT showed significant improvements across several physical outcomes in the cancer ...
High-intensity interval training in breast cancer survivorsMijwell et al. reported a compliance rate of 80 to 83% for HIIT plus resistance training and 57 to 75% for HIIT plus aerobic training across their studies.
HIIT boosts anti-cancer proteins and slows breast ...Research also shows that among breast cancer patients, exercise is associated with an approximately 20% lower risk for recurrence and mortality.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security